Bloody but Good ADMA

For those of you who have been watching ADMA over the last couple years... it has been a rough road to redemption for ADMA. Lots of bloody hits and bumps.

I see ADMA as a prime pick for a growth stock if you are looking to diversify your portfolio and add some health stocks.

You are getting in close to it's bottom but there is a lot of promise and hope for the future. It  recently received approval from the FDA for it's Knoxville Plasma center for interstate commerce of human source plasma and is on course to build 10 more facilities by 2024.

During these rocky and tumultuous times of uncertainty with COVID-19 on the rampage, it would only make sense to invest in the future by buying into the very sector that is a part of the supply chain for the manufacturing of plasma derived vaccines.

You are looking at only up with this stock pick.